Dr. Kharitonov is a senior executive with over 25 years of experience in pharmaceutical research and development, operational management, engineering and commercial manufacturing of pharmaceutical drug products.
Prior to joining ReCode Therapeutics in 2020, he held positions of increasing responsibility at Pacira Pharmaceuticals from 2000 through 2020 including Vice President of Research and Development since 2010. He led a team at Pacira focused on all aspects of Chemistry, Manufacturing and Controls (CMC), including formulation, analytical, process and nonclinical development that brought three liposomal products in the pain management and cancer treatment spaces through regulatory approvals in the U.S. and EU. Throughout his career he also led engineering, technology transfer and commercial manufacturing teams both, on-site and at CMO.
Dr. Kharitonov received his Ph.D. in Chemistry from Moscow State University and was a visiting scientist and faculty member at the Department of Medicine at the University of California, San Diego. He has published more than 40 peer-reviewed scientific articles on mechanisms of chemical reactions, biochemistry and biochemical kinetics.